<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Disruptive</title>
	<atom:link href="http://www.tapanray.in/tag/disruptive/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Appears On Radar New L&amp;D Needs For Pharma’s New e-Environment</title>
		<link>http://www.tapanray.in/appears-on-radar-new-ld-needs-for-pharmas-new-e-environment/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=appears-on-radar-new-ld-needs-for-pharmas-new-e-environment</link>
		<comments>http://www.tapanray.in/appears-on-radar-new-ld-needs-for-pharmas-new-e-environment/#comments</comments>
		<pubDate>Mon, 08 Mar 2021 00:00:40 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[behavior]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[changes]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[dynamics]]></category>
		<category><![CDATA[e-environment]]></category>
		<category><![CDATA[e-marketing]]></category>
		<category><![CDATA[employees]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[L&D]]></category>
		<category><![CDATA[learning]]></category>
		<category><![CDATA[long-haul]]></category>
		<category><![CDATA[Models]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[remote]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Telehealth]]></category>
		<category><![CDATA[training]]></category>
		<category><![CDATA[virtual]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10434</guid>
		<description><![CDATA[As drug companies were desperately trying to navigate through the operational disruptions due to Covid crisis, the Learning and Development (LD) plans of most organizations, considered so important for employees, got badly impacted. This was ably captured in the article &#8230; <a href="http://www.tapanray.in/appears-on-radar-new-ld-needs-for-pharmas-new-e-environment/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/appears-on-radar-new-ld-needs-for-pharmas-new-e-environment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Essential ‘Acrobatic Feat’ Remains Relevant Even In Digital Pharma World</title>
		<link>http://www.tapanray.in/an-essential-acrobatic-feat-remains-relevant-even-in-digital-pharma-world/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=an-essential-acrobatic-feat-remains-relevant-even-in-digital-pharma-world</link>
		<comments>http://www.tapanray.in/an-essential-acrobatic-feat-remains-relevant-even-in-digital-pharma-world/#comments</comments>
		<pubDate>Mon, 17 Feb 2020 00:00:53 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[' lifting his eyes to the hills']]></category>
		<category><![CDATA['keep his nose to the grindstone']]></category>
		<category><![CDATA[benefits]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[changes]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[Drucker]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[extrinsic]]></category>
		<category><![CDATA[features]]></category>
		<category><![CDATA[intrinsic]]></category>
		<category><![CDATA[Manager]]></category>
		<category><![CDATA[marketers]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[measurement]]></category>
		<category><![CDATA[parameters]]></category>
		<category><![CDATA[Peter]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[success]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[transformation]]></category>
		<category><![CDATA[treatment experience]]></category>
		<category><![CDATA[unique]]></category>
		<category><![CDATA[value]]></category>
		<category><![CDATA[‘Acrobatic Feat’]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9878</guid>
		<description><![CDATA[“A manager must, so to speak, keep his nose to the grindstone while lifting his eyes to the hills — quite an acrobatic feat!” This profound statement was articulated by the Management Guru of all-time – Peter F. Drucker, in his book &#8230; <a href="http://www.tapanray.in/an-essential-acrobatic-feat-remains-relevant-even-in-digital-pharma-world/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/an-essential-acrobatic-feat-remains-relevant-even-in-digital-pharma-world/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Challenge of Holistic Value Creation With Pharma M&amp;A</title>
		<link>http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-challenge-of-holistic-value-creation-with-pharma-ma</link>
		<comments>http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/#comments</comments>
		<pubDate>Mon, 19 Aug 2019 00:00:58 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[avant-garde]]></category>
		<category><![CDATA[Broader]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[creation]]></category>
		<category><![CDATA[cycle]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[greater]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovative]]></category>
		<category><![CDATA[launches]]></category>
		<category><![CDATA[M&A]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[merger]]></category>
		<category><![CDATA[NCE]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[NME]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[possibilities]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[redefining]]></category>
		<category><![CDATA[takeovers]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[unique]]></category>
		<category><![CDATA[value]]></category>
		<category><![CDATA[value-creation]]></category>
		<category><![CDATA[virtuous]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9675</guid>
		<description><![CDATA[Two mega deals, right at the dawn of 2019 gave a flying start to Merger &#38; Acquisition (M&#38;A) activities, in search of inorganic growth, by some large pharma companies. The two biggest ones are Bristol-Myers Squibb’s (BMS) USD 74 billion buyout of &#8230; <a href="http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Disruptive Impact of AI on Pharma Sales And Marketing</title>
		<link>http://www.tapanray.in/disruptive-impact-of-ai-on-pharma-sales-and-marketing/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=disruptive-impact-of-ai-on-pharma-sales-and-marketing</link>
		<comments>http://www.tapanray.in/disruptive-impact-of-ai-on-pharma-sales-and-marketing/#comments</comments>
		<pubDate>Mon, 15 Jul 2019 00:00:31 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[applications]]></category>
		<category><![CDATA[Artificial]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[creative]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[KOL]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[people]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[platforms]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[replace]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[transformation]]></category>
		<category><![CDATA[transformative]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9629</guid>
		<description><![CDATA[Artificial Intelligence (AI) that refers to the ability of machines to perform cognitive tasks like thinking, perceiving, learning, problem solving and decision making, is poised to disrupt our world. Initially conceived as a technology that could mimic human intelligence, AI &#8230; <a href="http://www.tapanray.in/disruptive-impact-of-ai-on-pharma-sales-and-marketing/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/disruptive-impact-of-ai-on-pharma-sales-and-marketing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Game is Changing: Ensure Better Treatment Outcomes: Leverage Technology</title>
		<link>http://www.tapanray.in/the-game-is-changing-ensure-better-treatment-outcomes-leverage-technology/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-game-is-changing-ensure-better-treatment-outcomes-leverage-technology</link>
		<comments>http://www.tapanray.in/the-game-is-changing-ensure-better-treatment-outcomes-leverage-technology/#comments</comments>
		<pubDate>Mon, 03 Jun 2019 00:00:38 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[augmentation]]></category>
		<category><![CDATA[basic]]></category>
		<category><![CDATA[changing]]></category>
		<category><![CDATA[Digihaler]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Leveraging]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[non-drug]]></category>
		<category><![CDATA[outcome]]></category>
		<category><![CDATA[patented]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[ProAir]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[replacement]]></category>
		<category><![CDATA[reSet]]></category>
		<category><![CDATA[Sandoz]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[Teva]]></category>
		<category><![CDATA[Therapeutics]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[types]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9570</guid>
		<description><![CDATA[Today, several pharma players, mostly ‘encouraged’ by many non-pharma tech companies, are trying to gain, at least, a toehold in the digital health care space. It is visible even within the generic drug industry. Such initiatives, as they gain a &#8230; <a href="http://www.tapanray.in/the-game-is-changing-ensure-better-treatment-outcomes-leverage-technology/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-game-is-changing-ensure-better-treatment-outcomes-leverage-technology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma Marketing: Time For A Disruptive Change with A New Breed of Marketers</title>
		<link>http://www.tapanray.in/pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers</link>
		<comments>http://www.tapanray.in/pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers/#comments</comments>
		<pubDate>Mon, 11 Mar 2019 00:00:51 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[breed]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[demands]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[environmental]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[fundamental]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[marketer]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[persona]]></category>
		<category><![CDATA[personality]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[pull]]></category>
		<category><![CDATA[Push]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[role]]></category>
		<category><![CDATA[services]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[success]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9440</guid>
		<description><![CDATA[In Today’s fast-changing world, as I indicated in several of my previous articles, more and more people first try to understand the causative factors of their ailments, and options available for effective remedial measures. They strive to get such information, &#8230; <a href="http://www.tapanray.in/pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-marketing-time-for-a-disruptive-change-with-a-new-breed-of-marketers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma’s Late Realization</title>
		<link>http://www.tapanray.in/pharmas-late-realization/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharmas-late-realization</link>
		<comments>http://www.tapanray.in/pharmas-late-realization/#comments</comments>
		<pubDate>Mon, 14 Aug 2017 00:00:08 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[divide]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[incremental]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[late]]></category>
		<category><![CDATA[never]]></category>
		<category><![CDATA[opportunity]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[realization]]></category>
		<category><![CDATA[solutions]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[tactics]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8348</guid>
		<description><![CDATA[Technology, by and large, is impacting almost every part of our life. Interestingly, some of these, like mobile phones and desktop computers, found their initial uses, mostly as trendy status symbols of relatively rich and high ranking corporate honchos, before &#8230; <a href="http://www.tapanray.in/pharmas-late-realization/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharmas-late-realization/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Disruptive Digital Innovation To Reduce Medication Need?</title>
		<link>http://www.tapanray.in/disruptive-digital-innovation-to-reduce-medication-need/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=disruptive-digital-innovation-to-reduce-medication-need</link>
		<comments>http://www.tapanray.in/disruptive-digital-innovation-to-reduce-medication-need/#comments</comments>
		<pubDate>Mon, 01 May 2017 00:00:33 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Alcon]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Google]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Innovators]]></category>
		<category><![CDATA[insurgents]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[Microsoft]]></category>
		<category><![CDATA[Notes]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Playbook]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reduce]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[startups]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8202</guid>
		<description><![CDATA[Application of digital technology in various spheres of not just business, but in our individual day to life also, promises a disruptive change for the better, from the traditional way of doing things and achieving goals &#8211; freeing a lot &#8230; <a href="http://www.tapanray.in/disruptive-digital-innovation-to-reduce-medication-need/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/disruptive-digital-innovation-to-reduce-medication-need/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Relevance of Artificial Intelligence In Creative Pharma Marketing</title>
		<link>http://www.tapanray.in/relevance-of-artificial-intelligence-in-creative-pharma-marketing/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=relevance-of-artificial-intelligence-in-creative-pharma-marketing</link>
		<comments>http://www.tapanray.in/relevance-of-artificial-intelligence-in-creative-pharma-marketing/#comments</comments>
		<pubDate>Sun, 30 Oct 2016 23:52:34 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[algorithm]]></category>
		<category><![CDATA[analytics]]></category>
		<category><![CDATA[Artificial]]></category>
		<category><![CDATA[cars]]></category>
		<category><![CDATA[creative]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[Driveless]]></category>
		<category><![CDATA[Eularis]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[Salesforce]]></category>
		<category><![CDATA[stakeholders]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7928</guid>
		<description><![CDATA[Keeping pace with the challenge of change globally, the macro environment in the pharma business is also undergoing a metamorphosis. This includes areas, such as, strong product pricing pressure, dwindling new product pipelines, increasing operating expenses, stringent regulatory requirements, rising &#8230; <a href="http://www.tapanray.in/relevance-of-artificial-intelligence-in-creative-pharma-marketing/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/relevance-of-artificial-intelligence-in-creative-pharma-marketing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma R&amp;D: Chasing A Rainbow To Replicate The Past</title>
		<link>http://www.tapanray.in/pharma-rd-chasing-a-rainbow-to-replicate-the-past/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-rd-chasing-a-rainbow-to-replicate-the-past</link>
		<comments>http://www.tapanray.in/pharma-rd-chasing-a-rainbow-to-replicate-the-past/#comments</comments>
		<pubDate>Mon, 25 Jan 2016 00:00:30 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Deloitte]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[discovery]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[eclectic]]></category>
		<category><![CDATA[exorbitant]]></category>
		<category><![CDATA[external]]></category>
		<category><![CDATA[Gilead]]></category>
		<category><![CDATA[Harmoni]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Nucala]]></category>
		<category><![CDATA[past]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[productivity]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[rainbow]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[replicate]]></category>
		<category><![CDATA[return]]></category>
		<category><![CDATA[Sovaldi]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Treshba]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7405</guid>
		<description><![CDATA[Would future be always a replica of the past? If the response is yes, the efforts of many global pharma players to replicate the successful Research and Development (R&#38;D) models of long gone by days, would continue to be a &#8230; <a href="http://www.tapanray.in/pharma-rd-chasing-a-rainbow-to-replicate-the-past/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-rd-chasing-a-rainbow-to-replicate-the-past/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
